scholarly article | Q13442814 |
P50 | author | Simon F Lacey | Q56978267 |
P2093 | author name string | Paul Frankel | |
Robert Chen | |||
Stephen J Forman | |||
David Snyder | |||
Ryotaro Nakamura | |||
Andrew Dagis | |||
Leslie Popplewell | |||
Auayporn Nademanee | |||
Maria Delioukina | |||
Anthony S Stein | |||
Mark H Kirschbaum | |||
Joel Conrad | |||
P433 | issue | 3 | |
P304 | page(s) | 432-440 | |
P577 | publication date | 2011-07-27 | |
P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
P1476 | title | A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation. | |
P478 | volume | 18 |
Q41474323 | Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial. |
Q35770734 | Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant |
Q26824498 | Fifty years of melphalan use in hematopoietic stem cell transplantation |
Q88778743 | Fludarabine and neurotoxicity in engineered T-cell therapy |
Q47903276 | Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMT. |
Q38351859 | New drug toxicities in the onco-nephrology world |
Q36176670 | Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation |
Q38488058 | Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation |
Q38202155 | Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis |
Q36036328 | Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial |
Q40460438 | Sequential chemotherapy followed by reduced-intensity conditioning and allogeneic haematopoietic stem cell transplantation in adult patients with relapse or refractory acute myeloid leukaemia: a survey from the Acute Leukaemia Working Party of EBMT. |
Search more.